Benjamin Morgan Scirica MD
Cardiologist and Director, Innovation, Cardiovascular Division, Brigham and Women's Hospital; Associate Professor of Medicine, Harvard Medical School; Senior Investigator, TIMI Study Group, Boston, MassachusettsDr. Benjamin Scirica graduated from Harvard Medical School and trained in internal medicine and cardiovascular medicine at Brigham and Women's Hospital in Boston, Massachusetts. He has a MPH health degree from Harvard School of Public Health. He is currently a Senior Investigator at the TIMI Study Group (an academic research organization based at Brigham and Women's Hospital that has performed over 70 clinical trials in atherosclerotic heart disease), an attending cardiologist and Director of Innovation at the cardiovascular division at Brigham and Women's Hospital, and an associate professor of medicine at Harvard Medical School.
His research interests center on the risk stratification, management, and CV risk reduction of patients with acute coronary syndromes and cardiometabolic disorders. He is the Director of the TIMI ECG Core Laboratory, which has analyzed over 20,000 continuous and static ECGs from multiple trials in acute coronary syndromes, including the ExTRACT-TIMI 25, CLARITY-TIMI 28, DISPERSE-2, PLATO, and MERLIN-TIMI 36 trials. He was principal investigator or co-investigator of the MERLIN-TIMI 36, AVANT GARDE-TIMI 43, TRA 2Pº-TIMI 50, SAVOR-TIMI 53, and CAMELLIA-TIMI 58 trials.
Dr. Scirica has authored or co-authored over 150 peer-reviewed articles, serves on the editorial board of ACCEL, and is a reviewer for multiple journals, including New England Journal, JAMA, The Lancet, Circulation, and Journal of the American College of Cardiology (JACC). He attend in the cardiac intensive care unit at Brigham and Women’s Hospital.
Positions:
Attending Cardiologist and Director, Innovation, Cardiovascular Division, Brigham and Women's Hospital; Associate Professor of Medicine, Harvard Medical School; Senior Investigator, TIMI Study Group, Boston, Massachusetts
Degrees:
MD: Harvard Medical School
MPH: Harvard School of Public Health
Postgraduate Training:
Fellowship (internal medicine and cardiovascular medicine): Brigham and Women's Hospital, Boston, Massachusetts
Research Interests:
Identification and application of novel cardiac biomarkers and electrocardiographic techniques
Disclosures
Dr. Scirica reports institutional research grants to Brigham and Women’s Hospital from AstraZeneca, Eisai, Merck, Novartis, NovoNordisk, and Pfizer. Consulting fees from AbbVie, Allergan, AstraZeneca, Boehringer Ingelheim, Eisai, Elsevier Practice Update Cardiology, Esperion, Hamni, Lexicon, Medtronic, Merck, NovoNordisk, and equity in Health [at] Scale.
Recent Contributions to PracticeUpdate:
- Dipeptidyl Peptidase-4 Inhibitors and Hospitalized Heart Failure
- The Association of Type 2 Diabetes With Lipoproteins, Insulin Resistance, and Rosuvastatin
- Incretin-Based Drugs and Heart Failure
- ACC 2016: Abstract Recommendations From Dr. Ben Scirica
- Metabolomic Profiling of Statin Use and Genetic Inhibition of HMG-CoA Reductase
- Post-Hospital Outcomes of Patients With AMI With Cardiogenic Shock
- In-Hospital Development of Cardiogenic Shock After Acute MI
- Amiloride and Hydrochlorothiazide in Glucose Tolerance and Blood Pressure
- Heart Failure Outcomes With Empagliflozin in Patients With Type 2 Diabetes at High Cardiovascular Risk
- Effect of Diabetes and Glycemic Control on Ischemic Stroke Risk in AF Patients